Search results
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 1 day agoThe US Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 2 days agoIdeally, these updated vaccines will be available in the fall. The Vaccines and Related Biological...
First Human Death From Bird Flu Puts Vaccine Stocks On The Map - Moderna (NASDAQ:MRNA), CureVac...
Benzinga· 13 hours agoVaccine stocks have been on the fly ever since a never-before-seen bird flu strain started infecting...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 1 day agoVaccine manufacturers Pfizer, Moderna and Novavax each told the panel they were prepared to make...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
Midland Reporter-Telegram· 1 day agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
Novavax says it will have an updated Covid vaccine - Washington Business Journal
The Business Journals· 14 hours agoGaithersburg’s Novavax Inc. (NASDAQ: NVAX) says it will have an updated Covid-19 vaccine ready in...
FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine
MedPage Today· 4 days agoIn the briefing document, the FDA staff gave a brief history of coronavirus vaccines, noting that...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 4 days agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...
COVID vaccine makers ready updated shots for fall immunization drive (NYSE:PFE)
Seeking Alpha· 2 days agoPfizer (PFE), BioNTech (BNTX), Moderna (MRNA) and Novavax (NVAX) reaffirm commitment to provide ...
FDA approves Moderna’s mRNA RSV vaccine
The Hill via Yahoo News· 7 days agoThe Food and Drug Administration (FDA) has approved Moderna’s RSV mRNA vaccine for adults older than 60 years. The approval makes RSV the second disease...